Critical role of calpain in spinal cord degeneration in Parkinson's disease

Authors

  • Supriti Samantaray,

    1. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA
    Search for more papers by this author
    • S. Samantaray and V. Knaryan contributed equally to this study.
  • Varduhi H. Knaryan,

    1. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA
    Search for more papers by this author
    • S. Samantaray and V. Knaryan contributed equally to this study.
  • Donald C. Shields,

    1. Department of Neurosurgery, The George Washington University, Washington, District of Columbia, USA
    Search for more papers by this author
  • Naren L. Banik

    Corresponding author
    1. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA
    • Address correspondence and reprint requests to Naren L. Banik, Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 309 CSB, Charleston, SC 29425, USA.

      E-mail: baniknl@musc.edu

    Search for more papers by this author

Abstract

While multiple molecular mechanisms contribute to midbrain nigrostriatal dopaminergic degeneration in Parkinson's disease (PD), the mechanism of damage in non-dopaminergic sites within the central nervous system, including the spinal cord, is not well-understood. Thus, to understand the comprehensive pathophysiology underlying this devastating disease, postmortem spinal cord tissue samples (cervical, thoracic, and lumbar segments) from patients with PD were analyzed compared to age-matched normal subjects or Alzheimer's disease for selective molecular markers of neurodegeneration and inflammation. Distal axonal degeneration, relative abundance of both sensory and motor neuron death, selective loss of ChAT+ motoneurons, reactive astrogliosis, microgliosis, increased cycloxygenase-2 (Cox-2) expression, and infiltration of T cells were observed in spinal cord of PD patients compared to normal subjects. Biochemical analyses of spinal cord tissues revealed associated inflammatory and proteolytic events (elevated levels of Cox-2, expression and activity of μ- and m-calpain, degradation of axonal neurofilament protein, and concomitantly low levels of endogenous inhibitor – calpastatin) in spinal cord of PD patients. Thus, pathologically upregulated calpain activity in spinal cords of patients with PD may contribute to inflammatory response-mediated neuronal death, leading to motor dysfunction.

image

We proposed calpain over-activation and calpain-calpastatin dysregulation driving in a cascade of inflammatory responses (microglial activation and T cell infiltration) and degenerative pathways culminating in axonal degeneration and neuronal death in spinal cord of Parkinson's disease patients. This may be one of the crucial mechanisms in the degenerative process.

Ancillary